Achieving HCV Elimination in the United States: Progress and Next Steps

In this online educational program, expert faculty explore what will be needed to achieve HCV elimination in the United States. Choose from 6 short foundational videos, 3 ClinicalThought commentaries, and a module with accompanying slideset that details answers to commonly asked questions on the management of key at-risk populations.

Downloadable Slidesets

In this downloadable slideset, Frederick L. Altice, MD, and Norah Terrault, MD, MPH, review current and emerging trends in the epidemiology of HCV infection in the United States with a focus on what these trends mean for strategies aimed at achieving HCV elimination.

Released: October 18, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review modeling data indicating critical steps needed to achieve HCV elimination targets in the United States: reaching at-risk populations, delivering multiple interventions, and personalizing interventions to optimize outcomes by risk group.

Released: October 24, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review how dramatic changes in the HCV treatment landscape have enabled high cure rates to be safely achieved across a wide range of patient populations, including those previously excluded from HCV therapy because of previous or ongoing injection drug use.

Released: October 18, 2017

In this downloadable slideset, Frederick L. Altice, MD, and Natasha Martin, DPhil, review the current structural, geographic, and patient-specific barriers to HCV elimination in the United States.

Released: October 27, 2017

In this downloadable slideset, Alain H. Litwin, MD, and Brianna L. Norton, DO, review the essential roles of primary care physicians in screening, diagnosing, treating, and referring patients infected with HCV to achieve key HCV elimination goals in the United States.

Released: October 27, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Norah Terrault, MD, MPH, discuss the evolving roles of hepatologists, gastroenterologists, and infectious disease clinicians in the current HCV treatment landscape and review important strategies that these specialists can take in moving toward the goals of HCV elimination in the United States.

Released: October 30, 2017

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?